Trade Name: SISTEMA ESSURE Technical Name: Female Contraceptive Devices ANVISA Registration Number: 80274190001 Hazard Class: IV - Maximum Risk Affected Models: ESS305 Affected Lot Numbers: All lots 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Comercial Commed Produtos Hospitalares Ltda; Bayer Health Care LLCI 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    2208
  • 날짜
    2017-02-23
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    Products in stock at distributors, hospitals or clinics should be segregated in order to prevent them from being inadvertently implanted. Contact the company to receive detailed guidance on picking up non-deployed units. ### UPDATED ON 07/18/2017, published in the Official Gazette of the Federal Government on July 10, 2017, RESOLUTION RE 1.846, OF JULY 7, 2017 - Repeal Resolution RE 457 of 17 / 02/2017, published in the DOU nº 36 of February 20, 2017, Section 01, fl.35, which had determined the collection, suspension of the importation, distribution and commercialization, use and dissemination of the product ESSURE, registration ANVISA nº 80274190001, registration process nº 25351.350321 / 2007-88, imported and registered in Brazil by the company COMERCIAL COMMED PRODUCTOS HOSPITALARES LTDA, CNPJ: 02.643.718 / 0001-21. ### Alert 1908 correlates with alert 2208.
  • 원인
    Anvisa suspended the importation, distribution, commercialization, use and dissemination of the "essure system" product throughout the national territory (re 457, dated 02/17/2017 - dou no. 36 - section 1, dated 02/20/2017) , as well as determined the collection of units of the product that were not implanted.
  • 조치
    Field Action Code 001/2017 triggered under the responsibility of the company CONERCIAL COMMED PRODUCTOS HOSPITALARES LTDA. Collection of units sold and not implemented.